Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT00870129
Conditions
Brain Cancer
Glioma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MRI and advanced MRI sequences
Brief summary:
Conditions
Brain Cancer
Glioma
Study ID
NCT00870129
Start date
Mar, 2009
Status verified date
Oct, 2025
Completion date
Sep, 2026
Anticipated
Primary completion date
Sep, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
135 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: MRI
Interventions
MRI and advanced MRI sequences
Primary outcome measure
Central contacts
Robert Young, MD
212-639-8196Sunitha Thakur, PhD
646-608-8262Locations
Memorial Sloan Kettering Cancer Center
Recruiting
New York, New York, United States, 10065
Contacts
Robert Young, MD
212-639-8196Principal Investigator:
Robert Young, MD
Sponsor
Memorial Sloan Kettering Cancer Center
Last update posted
Oct 10, 2025
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-10-10.